The effect of pramlintide acetate on glycemic control and weight in patients with type 2 diabetes mellitus and in obese patients without diabetes: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

The effect of pramlintide acetate on glycemic control and weight in patients with type 2 diabetes mellitus and in obese patients without diabetes: a systematic review and meta-analysis

Published:2010-12-27 Issue:2 Volume:13 Page:169-180
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:

Author:

Singh-Franco D.,Perez A.,Harrington C.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2010.01337.x/fullpdf

Reference27 articles.

1. Symlin [package insert]. San Diego, CA: Amylin Pharmaceuticals, Inc., 2008

2. Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes.;Chapman;Diabetologia,2005

3. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes.;Nathan;Diabetes Care,2009

4. Pramlintide improved glycemic control and reduced weight in patients with type 2 diabetes using basal insulin.;Riddle;Diabetes Care,2007

5. Cochrane Handbook for Systematic Reviews of Interventions

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Body Fat Depletion: the Yin Paradigm for Treating Type 2 Diabetes;Current Atherosclerosis Reports;2023-12-27

2. Structural insight into selectivity of amylin and calcitonin receptor agonists;Nature Chemical Biology;2023-08-03

3. Diabesity and the Kidney;Frontiers in Clinical Drug Research-Diabetes and Obesity: Volume 7;2023-03-14

4. The Underutilization of Pramlintide as Adjunct Therapy in Type 1 and Type 2 Diabetes;ADCES in Practice;2023-01-27

5. Pharmacotherapy of type 2 diabetes: An update and future directions;Metabolism;2022-12